Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-09-08 Sale |
2021-09-09 4:15 pm |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks |
11,000 | $28.45 | $312,950 | 581,548 (Indirect Direct) |
View |
2021-08-10 Sale |
2021-08-26 7:11 pm |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks |
11,000 | $27 | $297,000 | 592,548 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2023-02-17 Option Award |
2023-02-21 6:53 pm |
N/A 2033-02-16 |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick Chief Scientific Officer |
115,500 | $0 | 494,434 (Direct) |
View |
2022-02-11 Option Award |
2022-02-15 4:48 pm |
N/A 2032-02-10 |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks |
112,500 | $0 | 453,934 (Direct) |
View |
2021-09-08 Exercise |
2021-09-09 4:15 pm |
N/A 2030-10-28 |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks |
11,000 | $0 | 581,548 (Direct) |
View |
2021-09-08 Exercise |
2021-09-09 4:15 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks |
11,000 | $4.3 | 581,548 (Direct) |
View |
2021-08-10 Exercise |
2021-08-26 7:11 pm |
N/A 2030-10-28 |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks |
11,000 | $0 | 592,548 (Direct) |
View |
2021-08-10 Exercise |
2021-08-26 7:11 pm |
N/A N/A |
Cullinan Oncology Inc. | CGEM | Baeuerle Patrick See Remarks |
11,000 | $4.3 | 592,548 (Direct) |
View |
2021-01-07 Option Award |
2021-01-11 5:37 pm |
N/A 2031-01-06 |
Cullinan Management Inc. | CGEM | Baeuerle Patrick See Remarks |
286,665 | $0 | 286,665 (Direct) |
View |
Ownership |
2021-01-07 8:34 pm |
N/A N/A |
Cullinan Management Inc. | CGEM | Baeuerle Patrick See Remarks |
0 | $0 | 1,011,541 (Indirect) |
View |
2020-12-10 Option Award |
2020-12-11 06:16 am |
N/A 2030-12-09 |
TCR2 THERAPEUTICS INC. | TCRR | Baeuerle Patrick Director |
12,100 | $0 | 362,886 (Direct) |
View |
2020-05-28 Option Award |
2020-06-01 9:38 pm |
N/A 2030-05-27 |
Harpoon Therapeutics Inc. | HARP | Baeuerle Patrick Director |
12,751 | $0 | 12,751 (Direct) |
View |